The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Ebselen in Acute Ischemic Stroke: A Placebo-Controlled, Double-blind Clinical Trial
Open accessAbstract
Background and Purpose —The effect of ebselen, a seleno-organic compound with antioxidant activity through a glutathione peroxidase–like action, on the outcome of acute ischemic stroke was evaluated in a multicenter, placebo-controlled, double-blind clinical trial. Methods —Patients diagnosed as having acute ischemic stroke who could receive drug treatment within 48 hours of stroke onset were enrolled. Oral administration of ebselen granules suspended in water (150 mg BID) or placebo was started immediately after admission and was continued for 2 weeks. The major end points were the Glasgow Outcome Scale scores at 1 month and 3 months after the start of treatment. The modified Mathew Scale and modified Barthel Index scores at 1 month and 3 months were also studied as secondary outcome measures. Results —Three hundred two patients were enrolled in the trial. Intent-to-treat analysis of 300 patients (151 given ebselen and 149 given placebo) revealed that ebselen treatment achieved a significantly better outcome than placebo at 1 month ( P =.023, Wilcoxon rank sum test) but not at 3 months ( P =.056, Wilcoxon rank sum test). The improvement was significant in patients who started ebselen within 24 hours of stroke onset but not in those who started treatment after 24 hours. There was a corresponding improvement in the modified Mathew Scale and modified Barthel Index scores. Conclusions —Early treatment with ebselen improved the outcome of acute ischemic stroke. Ebselen may be a promising neuroprotective agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501 · cited 3×
“3 mo 0-34 12 (15) 19 (21) 0-49 39 (50) 54 (59) G 20 (26)§ 10 (11)”
Fisher, C. M., Kistler, J. P., & Davis, J. M. (1980) · Neurosurgery · doi:10.1227/00006123-198001000-00001 · Cited by 3,080
Pathophysiology and treatment of focal cerebral ischemia: Part I: Pathophysiology
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0169 · Cited by 1,295
A novel biologically active seleno-organic compound—1
Müller, A., Cadenas, E., Graf, P., & Sies, H. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90083-2 · Cited by 828
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.3.0337 · Cited by 657
Central nervous system trauma and stroke
Hall, E. D., & Braughler, J. M. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90057-9 · Cited by 586
A novel biologically active seleno-organic compound—II
Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., & Otter, R. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90084-4 · Cited by 433
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
Gelmers, H. J., Gorter, K., de Weerdt, C. J., & Wiezer, H. J. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180402 · Cited by 419
Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis
Zini, I., Tomasi, A., Grimaldi, R., Vannini, V., & Agnati, L. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90933-x · Cited by 185
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
Nogueira, C. W., Zeni, G., & Rocha, J. B. T. (2004) · Chemical Reviews · doi:10.1021/cr0406559 · Cited by 1,926
Redox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health
Papp, L. V., Lu, J., Holmgren, A., & Khanna, K. K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1528 · Cited by 1,338
Lubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280
Glutamate receptors, neurotoxicity and neurodegeneration
Lau, A., & Tymianski, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0809-1 · Cited by 1,185
Use of the Barthel Index and Modified Rankin Scale in Acute Stroke Trials
Sulter, G., Steen, C., & Keyser, J. D. (1999) · Stroke · doi:10.1161/01.str.30.8.1538 · Cited by 1,117
Oxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke
Allen, C. L., & Bayraktutan, U. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00387.x · Cited by 966
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181486 · Cited by 904
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Oxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Weekley, C. M., & Harris, H. H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60272a · Cited by 629
Selenium: its role as antioxidant in human health
Tinggi, U. (2008) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-007-0019-4 · Cited by 607
Oxidants, antioxidants and the ischemic brain
Warner, D. S., Sheng, H., & Batinić-Haberle, I. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01022 · Cited by 598
Antioxidant Therapy in Acute Central Nervous System Injury: Current State
Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., & Offen, D. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.271 · Cited by 568
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Duncan, P. W., Jorgensen, H. S., & Wade, D. T. (2000) · Stroke · doi:10.1161/01.str.31.6.1429 · Cited by 484
Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds
Nogueira, C. W., & Rocha, J. B. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0720-3 · Cited by 477
Battin, E. E., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9054-7 · Cited by 476
Antioxidant Therapy: Current Status and Future Prospects
Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414368 · Cited by 468
Mechanisms of methylmercury-induced neurotoxicity: Evidence from experimental studies
Farina, M., Rocha, J. B. T., & Aschner, M. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.019 · Cited by 445
Heyland, D. K., Dhaliwal, R., Suchner, U., & Berger, M. M. (2005) · Intensive Care Medicine · doi:10.1007/s00134-004-2522-z · Cited by 438
Antioxidant strategies in the treatment of stroke
Margaill, I., Plotkine, M., & Lerouet, D. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.003 · Cited by 405
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
De Keyser, J., Sulter, G., & Luiten, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01463-0 · Cited by 374
Oxidative and nitrosative stress in acute renal ischemia
Noiri, E., Nakao, A., Uchida, K., Tsukahara, H., Ohno, M., Fujita, T., Brodsky, S., & Goligorsky, M. S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0071.2001 · Cited by 366
Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System
Ren, X., Zou, L., Zhang, X., Branco, V., Wang, J., Carvalho, C., Holmgren, A., & Lu, J. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6925 · Cited by 361
Oxidative stress in early diabetic nephropathy: fueling the fire
Singh, D. K., Winocour, P., & Farrington, K. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.212 · Cited by 353
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
Azad, G. K., & Tomar, R. S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3417-x · Cited by 343
Selenoproteins: Antioxidant selenoenzymes and beyond
Steinbrenner, H., Speckmann, B., & Klotz, L.-O. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.06.024 · Cited by 327
Natural and synthetic antioxidants: An updated overview
Augustyniak, A., Bartosz, G., Čipak, A., Duburs, G., Horáková, L., Łuczaj, W., Majekova, M., Odysseos, A. D., Rackova, L., Skrzydlewska, E., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.508495 · Cited by 319
The biochemistry of selenium and the glutathione system
Arteel, G. E., & Sies, H. (2001) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(01)00078-3 · Cited by 314
Protection against peroxynitrite
Arteel, G. E., Briviba, K., & Sies, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00073-3 · Cited by 305
Free radicals as triggers of brain edema formation after stroke
Heo, J. H., Han, S. W., & Lee, S. K. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.035 · Cited by 305
The role of glutathione peroxidase-1 in health and disease
Handy, D. E., & Loscalzo, J. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.004 · Cited by 285
Oxidative Stress and the Use of Antioxidants in Stroke
Shirley, R., Ord, E., & Work, L. (2014) · Antioxidants · doi:10.3390/antiox3030472 · Cited by 282
New Insights on NOX Enzymes in the Central Nervous System
Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279
Catalase and glutathione peroxidase mimics
Day, B. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.029 · Cited by 269
Herrera, D. G., Yagüe, A. G., Johnsen-Soriano, S., Bosch-Morell, F., Collado-Morente, L., Muriach, M., Romero, F. J., & García-Verdugo, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1230907100 · Cited by 269
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
A safe lithium mimetic for bipolar disorder
Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O. V., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I., Sharp, T., Vasudevan, S. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms2320 · Cited by 258
Zhao, R., Masayasu, H., & Holmgren, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122061399 · Cited by 254
Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis
Manzanares, W., Dhaliwal, R., Jiang, X., Murch, L., & Heyland, D. K. (2012) · Critical Care · doi:10.1186/cc11316 · Cited by 234
The Optimising Analysis of Stroke Trials (OAST) Collaboration (2007) · Stroke · doi:10.1161/strokeaha.106.474080 · Cited by 192
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Potts, M. B., Koh, S.-E., Whetstone, W. D., Walker, B. A., Yoneyama, T., Claus, C. P., Manvelyan, H. M., & Noble-Haeusslein, L. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.006 · Cited by 164
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Manzanares, W., Lemieux, M., Elke, G., Langlois, P. L., Bloos, F., & Heyland, D. K. (2016) · Critical Care · doi:10.1186/s13054-016-1529-5 · Cited by 100
Posser, T., Kaster, M. P., Baraúna, S. C., Rocha, J. B. T., Rodrigues, A. L. S., & Leal, R. B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.055 · Cited by 86
Weaver, C. S., Leonardi-Bee, J., Bath-Hextall, F. J., & Bath, P. M. W. (2004) · Stroke · doi:10.1161/01.str.0000125010.70652.93 · Cited by 67
Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors?
The Optimising the Analysis of Stroke Trials (OAST) Collaboration (2009) · Stroke · doi:10.1161/strokeaha.108.519207 · Cited by 64
Deletion of NADPH oxidase 4 reduces severity of traumatic brain injury
Ma, M. W., Wang, J., Dhandapani, K. M., & Brann, D. W. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.031 · Cited by 52
Samsa, G. P., & Matchar, D. B. (2001) · Stroke · doi:10.1161/01.str.32.3.669 · Cited by 51
Metadata
- Authors
- Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., & Yasuhara, H.
- Venue
- Stroke
- Published
- 1998-01
- Volume
- 29
- Issue
- 1
- Pages
- 12-17
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1965476204
- Cited by
- 610
- References
- 20
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.